Literature DB >> 8600455

Copurification of casein kinase II with transcription factor ATF/E4TF3.

T Wada1, T Takagi, Y Yamaguchi, H Kawase, M Hiramoto, A Ferdous, M Takayama, K A Lee, H C Hurst, H Handa.   

Abstract

We have developed a simple method to purify sequence-specific DNA-binding proteins directly from crude cell extracts by using DNA affinity latex beads. The method enabled us to purify not only DNA-binding proteins, but also their associated proteins. Using beads bearing the ATF/E4TF3 site from the adenovirus E4 gene promoter, a protein kinase activity was copurified with the ATF/E4TF3 family. We found that the kinase interacted with ATF1 in vitro efficiently. The kinase did not bind directly to DNA. The kinase mainly phosphorylated ATF1 on serine 36, which was one of target amino acids for casein kinase (CK) II. Biological features of the kinase were the same as those of CKII and an anti-CKII serum reacted with the kinase, indicating that the kinase was CKII. Moreover, it was clearly shown that one of CKII subunits, the CKII alpha protein bound to glutathione-S-transferase (GST) fusion ATF1 but not GST in vitro. It has been reported that a specific CKII inhibitor, 5,6-dichloro-1-beta-D-ribo-furanosylbenzimidazole (DRB) inhibits transcription by RNA polymerase II [Zandomeni et al., (1986) J. Biol. Chem. 261, 3414-3419]. Taken together, these results suggest that ATF/E4TF3 may recruit the CKII activity to a transcription initiation machinery and stimulate transcription.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8600455      PMCID: PMC145718          DOI: 10.1093/nar/24.5.876

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  50 in total

1.  Transcriptional elongation by RNA polymerase II is stimulated by transactivators.

Authors:  K Yankulov; J Blau; T Purton; S Roberts; D L Bentley
Journal:  Cell       Date:  1994-06-03       Impact factor: 41.582

2.  Effects of activation-defective TBP mutations on transcription initiation in yeast.

Authors:  T K Kim; S Hashimoto; R J Kelleher; P M Flanagan; R D Kornberg; M Horikoshi; R G Roeder
Journal:  Nature       Date:  1994-05-19       Impact factor: 49.962

Review 3.  Xeroderma pigmentosum and nucleotide excision repair of DNA.

Authors:  K Tanaka; R D Wood
Journal:  Trends Biochem Sci       Date:  1994-02       Impact factor: 13.807

4.  Unusual charge configurations in transcription factors of the basic RNA polymerase II initiation complex.

Authors:  S Karlin
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

5.  Nuclear protein CBP is a coactivator for the transcription factor CREB.

Authors:  R P Kwok; J R Lundblad; J C Chrivia; J P Richards; H P Bächinger; R G Brennan; S G Roberts; M R Green; R H Goodman
Journal:  Nature       Date:  1994-07-21       Impact factor: 49.962

6.  The p53 activation domain binds the TATA box-binding polypeptide in Holo-TFIID, and a neighboring p53 domain inhibits transcription.

Authors:  X Liu; C W Miller; P H Koeffler; A J Berk
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

Review 7.  DRTF1/E2F: an expanding family of heterodimeric transcription factors implicated in cell-cycle control.

Authors:  N B La Thangue
Journal:  Trends Biochem Sci       Date:  1994-03       Impact factor: 13.807

8.  In vitro phosphorylation studies of a conserved region of the transcription factor ATF1.

Authors:  N Masson; J John; K A Lee
Journal:  Nucleic Acids Res       Date:  1993-09-11       Impact factor: 16.971

9.  Human casein kinase II. The subunit alpha protein activates transcription of the subunit beta gene.

Authors:  A Robitzki; L Bodenbach; H Voss; W Pyerin
Journal:  J Biol Chem       Date:  1993-03-15       Impact factor: 5.157

10.  Multiple and cooperative phosphorylation events regulate the CREM activator function.

Authors:  R P de Groot; J den Hertog; J R Vandenheede; J Goris; P Sassone-Corsi
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

View more
  8 in total

1.  H11 has dose-dependent and dual hypertrophic and proapoptotic functions in cardiac myocytes.

Authors:  Makoto Hase; Christophe Depre; Stephen F Vatner; Junichi Sadoshima
Journal:  Biochem J       Date:  2005-06-01       Impact factor: 3.857

2.  Role of protein kinase CK2 in phosphorylation nucleosomal proteins in relation to transcriptional activity.

Authors:  C Guo; A T Davis; S Yu; S Tawfic; K Ahmed
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

3.  DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs.

Authors:  T Wada; T Takagi; Y Yamaguchi; A Ferdous; T Imai; S Hirose; S Sugimoto; K Yano; G A Hartzog; F Winston; S Buratowski; H Handa
Journal:  Genes Dev       Date:  1998-02-01       Impact factor: 11.361

4.  Adeno-associated virus site-specific integration is regulated by TRP-185.

Authors:  Noriaki Yamamoto; Masato Suzuki; Masa-Aki Kawano; Takamasa Inoue; Ryou-U Takahashi; Hiroko Tsukamoto; Teruya Enomoto; Yuki Yamaguchi; Tadashi Wada; Hiroshi Handa
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

5.  Ability of CK2beta to selectively regulate cellular protein kinases.

Authors:  Birgitte B Olsen; Barbara Guerra
Journal:  Mol Cell Biochem       Date:  2008-06-17       Impact factor: 3.396

6.  Casein kinase II interacts with the bZIP domains of several transcription factors.

Authors:  Y Yamaguchi; T Wada; F Suzuki; T Takagi; J Hasegawa; H Handa
Journal:  Nucleic Acids Res       Date:  1998-08-15       Impact factor: 16.971

7.  Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro.

Authors:  T Wada; T Takagi; Y Yamaguchi; D Watanabe; H Handa
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

8.  Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta.

Authors:  Ayman S El-Guindy; George Miller
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.